Global Information
회사소개 | 문의 | 비교리스트

세계의 멀티플렉스 어세이(분자 다중화) 시장 : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년)

Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)

리서치사 Koncept Analytics
발행일 2020년 07월 상품 코드 948343
페이지 정보 영문 117 Pages
가격
US $ 1,800 ₩ 2,156,000 PDF (Single User License)
US $ 2,400 ₩ 2,875,000 PDF (Corporate User License)


세계의 멀티플렉스 어세이(분자 다중화) 시장 : COVID-19의 잠재적 영향에 관한 인사이트와 예측(2020-2024년) Global Multiplex Assays (Molecular Multiplexing) Market: Insights & Forecast with Potential Impact of COVID-19 (2020-2024)
발행일 : 2020년 07월 페이지 정보 : 영문 117 Pages

세계의 멀티플렉스 어세이 시장은 2020-2024년간 7.18%의 CAGR로 확대되어 2024년에는 48억 7,000만 달러에 달할 것으로 예측됩니다. 시장 확대의 원동력이 되는 것은 HIV 감염증 유병률 상승, 신규 암환자 증례 증가, 의료 기술 연구개발에 대한 지출 증가, 고령자 인구 증가, 의료비 급증, Drug Discovery 분야에서의 멀티플렉스 면역측정 이용 확대, 동반진단 보급 확대, 제약 업계와 바이오테크놀러지 업계에서의 합병과 인수, 자가면역질환 분야에서의 바이오시밀러 동향, 다중 Point of Care 검사(xPOCT) 수요 확대 등의 요인입니다.

세계의 멀티플렉스 어세이 시장을 조사했으며, 신종 코로나바이러스 감염증(COVID-19) 팬데믹의 영향, 세계 시장과 각 지역 시장 분석, 시장 역학, 경쟁 상황, 기업 개요 등의 정보를 제공합니다.

목차

제1장 개요

  • 서론
  • 기존 어세이와 멀티플렉스 어세이의 차이
  • 분자 다중화 성공 요인
  • 다중화 플랫폼
  • 멀티플렉스 어세이의 미래

제2장 COVID-19의 영향

  • COVID-19 검사 증가
  • 각국 정부의 의료비 지출 증가
  • 의료 분야의 인공지능 도입 확대
  • 지역적인 영향

제3장 세계 시장 분석

  • 금액 기준 시장
  • 금액 기준 시장 예측
  • 제품별 시장
    • 소모품
    • 기기
    • 소프트웨어
  • 용도별 시장
    • 연구개발
    • 임상진단
    • 동반진단
  • 최종사용자별 시장
    • 제약회사와 바이오테크놀러지 기업
    • 연구기관
    • 임상 검사실
    • 병원
  • 지역별 시장

제4장 지역 시장 분석

  • 북미
  • 아시아태평양
  • 유럽
  • 라틴아메리카
  • 중동 및 아프리카

제5장 시장 역학

  • 성장 촉진요인
    • HIV 감염증 유병률 상승
    • 신규 암환자 증례 증가
    • 의료 기술 연구개발비 증가
    • 고령자 인구 증가
    • 의료비 급증
    • Drug Discovery 분야에서의 멀티플렉스 면역측정 이용 확대
    • 동반진단 보급 확대
  • 주요 동향과 개발
    • 감염증 발증률 상승
    • 제약 업계와 바이오테크놀러지 업계에서의 합병과 인수 증가
    • 자가면역질환 분야의 바이오시밀러 동향
    • 다중 Point of Care 검사(xPOCT) 수요
  • 과제
    • 숙련된 전문가 부족
    • 고액의 투자 자본
    • 각국 정부의 엄격한 규제

제6장 경쟁 상황

  • 세계 시장
    • 주요 기업의 매출 비교
    • 주요 기업의 연구개발 지출 비교
    • 주요 기업의 시가총액 비교

제7장 기업 개요

  • Thermo Fisher Scientific
    • 재무 개요
    • 재무 개요
    • 사업 전략
  • Becton, Dickinson and Company(BD)
    • 재무 개요
    • 재무 개요
    • 사업 전략
  • BioMerieux
    • 사업 개요
    • 재무 개요
    • 사업 전략
  • Bio-Rad Laboratories
    • 사업 개요
    • 재무 개요
    • 사업 전략
  • Qiagen
    • 사업 개요
    • 재무 개요
    • 사업 전략
  • Luminex Corporation
    • 사업 개요
    • 재무 개요
    • 사업 전략
KSM 20.07.29

List of Tables

  • Determinants of Successful Molecular Multiplexing
  • Multiplexing Platforms
  • COVID-19 Test per Million Population
  • Key Players - Revenue Comparison (2019)
  • Key Players - R&D Expenditure Comparison (2019)
  • Key Players - Market Capitalization Comparison (2020)

The global multiplex assays market is expected to reach US$4.87 billion in 2024, increasing at a CAGR of 7.18%, for the duration spanning 2020-2024. The factors such as increasing prevalence of HIV, rising incidences of cancer cases, increasing medical technology R&D spending, growth in geriatric population, upsurge in healthcare expenditures, rise of multiplex immunoassays in drug discovery and escalating adoption of companion diagnostics would drive the growth of the market. However, the market growth would be challenged by dearth of skilled professionals, high investment capital for multiplex assays and stringent government regulations. A few notable trends may include accelerating growth rates of infectious diseases, growth in pharmaceutical and biotech merger & acquisition, monitoring of biosimilar in autoimmune diseases and demand for multiplexed point-of-care tests (xPOCT).

The global multiplex assays market has been segmented into consumables, instruments and software, based on product type. Consumables dominate the market owing to the increase in the number of testing procedures, performed across research institutes, clinical labs and others. Instruments and software have also hold considerable shares in the global market owing to the technological advancement and product innovation, which have eased the entire process of medical research.

The fastest growing regional market is North America, due to the consistent growth in the M&A between the pharmaceutical and biotechnological companies, which have led to the expansion of the research field in the healthcare sector. Further, the sudden outbreak of COVID-19 is causing an adverse disruption in the global population, augmenting the need for precise diagnostic as well as therapeutic option, which is expected to drive the growth of the global multiplex assays market during the forecasted period.

Scope of the report:

The report provides a comprehensive analysis of the global multiplex assays market.

The major regional markets (North America, Asia-Pacific, Europe, Latin America and Middle East & Africa) have been analyzed.

The market dynamics such as growth drivers, market trends and challenges are analyzed in-depth.

The competitive landscape of the market, along with the company profiles of leading players (Thermo Fisher Scientific, Becton, Dickson and Company (BD), BioMerieux, Bio-Rad Laboratories, Qiagen and Luminex Corporation) are also presented in detail.

Key Target Audience:

  • Multiplex Assays Kit Manufacturers
  • Medical Technology and Pharmaceutical Firms
  • End Users (pharma & biotech companies, research institutes, clinical labs and hospitals)
  • Investment Banks
  • Healthcare and Medical Consultants
  • Government Bodies & Regulating Authorities

Table of Contents

1. Overview

  • 1.1. Introduction
  • 1.2. Difference Between Traditional Assay and Multiplex Assay
  • 1.3. Determinants of Successful Molecular Multiplexing
  • 1.4. Multiplexing Platforms
  • 1.5. The Future of Multiplex Assays

2. Impact of COVID-19

  • 2.1. Rise in Number of COVID-19 Test
  • 2.2. Growth in Government Spending on Healthcare
  • 2.3. Rise in Adoption of Artificial Intelligence in Healthcare
  • 2.4. Regional Impact

3. Global Market Analysis

  • 3.1. Global Multiplex Assays Market by Value
  • 3.2. Global Multiplex Assays Market Forecast by Value
  • 3.3. Global Multiplex Assays Market by Product
    • 3.3.1. Global Multiplex Assays Consumables Market by Value
    • 3.3.2. Global Multiplex Assays Consumables Market Forecast by Value
    • 3.3.3. Global Multiplex Assays Instruments Market by Value
    • 3.3.4. Global Multiplex Assays Instruments Market Forecast by Value
    • 3.3.5. Global Multiplex Assays Software Market by Value
    • 3.3.6. Global Multiplex Assays Software Market Forecast by Value
  • 3.4. Global Multiplex Assays Market by Application
    • 3.4.1. Global Multiplex Assays Research & Development Market by Value
    • 3.4.2. Global Multiplex Assays Research & Development Market Forecast by Value
    • 3.4.3. Global Multiplex Assays Clinical Diagnostics Market by Value
    • 3.4.4. Global Multiplex Assays Clinical Diagnostics Market Forecast by Value
    • 3.4.5. Global Multiplex Assays Companion Diagnostics Market by Value
    • 3.4.6. Global Multiplex Assays Companion Diagnostics Market Forecast by Value
  • 3.5. Global Multiplex Assays Market by End-Users
    • 3.5.1. Global P&B Companies Multiplex Assays Market by Value
    • 3.5.2. Global P&B Companies Multiplex Assays Market Forecast by Value
    • 3.5.3. Global Research Institutes Multiplex Assays Market by Value
    • 3.5.4. Global Research Institutes Multiplex Assays Market Forecast by Value
    • 3.5.5. Global Clinical Labs Multiplex Assays Market by Value
    • 3.5.6. Global Clinical Labs Multiplex Assays Market Forecast by Value
    • 3.5.7. Global Hospital Multiplex Assays Market by Value
    • 3.5.8. Global Hospital Multiplex Assays Market Forecast by Value
  • 3.6. Global Multiplex Assays Market by Region

4. Regional Market Analysis

  • 4.1. North America
    • 4.1.1. North America Multiplex Assays Market by Value
    • 4.1.2. North America Multiplex Assays Market Forecast by Value
  • 4.2. Asia-Pacific
    • 4.2.1. Asia-Pacific Multiplex Assays Market by Value
    • 4.2.2. Asia-Pacific Multiplex Assays Market Forecast by Value
  • 4.3. Europe
    • 4.3.1. Europe Multiplex Assays Market by Value
    • 4.3.2. Europe Multiplex Assays Market Forecast by Value
  • 4.4. Latin America
    • 4.4.1. Latin America Multiplex Assays Market by Value
    • 4.4.2. Latin America Multiplex Assays Market Forecast by Value
  • 4.5. Middle East & Africa
    • 4.5.1. Middle East & Africa Multiplex Assays Market by Value
    • 4.5.2. Middle East & Africa Multiplex Assays Market Forecast by Value

5. Market Dynamics

  • 5.1. Growth Drivers
    • 5.1.1. Increasing Prevalence of HIV Infections
    • 5.1.2. Rising Incidences of New Cancer Cases
    • 5.1.3. Increasing Medical Technology R&D Spending
    • 5.1.4. Growth in Geriatric Population
    • 5.1.5. Upsurge in Healthcare Expenditures
    • 5.1.6. Rise of Multiplex Immunoassays in Drug Discovery
    • 5.1.7. Escalating Adoption of Companion Diagnostics
  • 5.2. Key Trends and Developments
    • 5.2.1. Accelerating Growth Rates of Infectious Diseases
    • 5.2.2. Growth in Pharmaceutical and Biotech Merger & Acquisition
    • 5.2.3. Monitoring of Biosimilar in Autoimmune Diseases
    • 5.2.4. Demand for Multiplexed Point-of-Care Tests (xPOCT)
  • 5.3. Challenges
    • 5.3.1. Dearth of Skilled Professionals
    • 5.3.2. High Investment Capital for Multiplex Assays
    • 5.3.3. Stringent Government Regulations

6. Competitive Landscape

  • 6.1. Global Market
    • 6.1.1. Key Players - Revenue Comparison
    • 6.1.2. Key Players - R&D Expenditure Comparison
    • 6.1.3. Key Players - Market Capitalization Comparison

7. Company Profiles

  • 7.1. Thermo Fisher Scientific
    • 7.1.1. Financial Overview
    • 7.1.2. Financial Overview
    • 7.1.3. Business Strategies
  • 7.2. Becton, Dickinson and Company (BD)
    • 7.2.1. Financial Overview
    • 7.2.2. Financial Overview
    • 7.2.3. Business Strategies
  • 7.3. BioMerieux
    • 7.3.1. Business Overview
    • 7.3.2. Financial Overview
    • 7.3.3. Business Strategies
  • 7.4. Bio-Rad Laboratories
    • 7.4.1. Business Overview
    • 7.4.2. Financial Overview
    • 7.4.3. Business Strategies
  • 7.5. Qiagen
    • 7.5.1. Business Overview
    • 7.5.2. Financial Overview
    • 7.5.3. Business Strategies
  • 7.6. Luminex Corporation
    • 7.6.1. Business Overview
    • 7.6.2. Financial Overview
    • 7.6.3. Business Strategies

List of figures

  • Difference Between Traditional Assay and Multiplex Assay
  • Factors for the Rising Adoption of Multiplex Assays
  • Global Government Share on Health Spending (2019-2024)
  • Global Healthcare Artificial Intelligence (AI) Market Forecast (2017-2021)
  • Global Multiplex Assays Market by Value (2015-2019)
  • Global Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Product (2019)
  • Global Multiplex Assays Consumables Market by Value (2015-2019)
  • Global Multiplex Assays Consumables Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Instruments Market by Value (2015-2019)
  • Global Multiplex Assays Instruments Forecast by Value (2020-2024)
  • Global Multiplex Assays Software Market by Value (2015-2019)
  • Global Multiplex Assays Software Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Application (2019)
  • Global Multiplex Assays Research & Development Market by Value (2015-2019)
  • Global Multiplex Assays Research & Development Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Clinical Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Clinical Diagnostics Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Companion Diagnostics Market by Value (2015-2019)
  • Global Multiplex Assays Companion Diagnostics Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by End-Users (2019)
  • Global P&B Companies Multiplex Assays Market by Value (2015-2019)
  • Global P&B Companies Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Research Institutes Multiplex Assays Market by Value (2015-2019)
  • Global Research Institutes Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Clinical Labs Multiplex Assays Market by Value (2015-2019)
  • Global Clinical Labs Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Hospital Multiplex Assays Market by Value (2015-2019)
  • Global Hospital Multiplex Assays Market Forecast by Value (2020-2024)
  • Global Multiplex Assays Market by Region (2019)
  • North America Multiplex Assays Market by Value (2015-2019)
  • North America Multiplex Assays Market Forecast by Value (2020-2024)
  • Asia-Pacific Multiplex Assays Market by Value (2015-2019)
  • Asia-Pacific Multiplex Assays Market Forecast by Value (2020-2024)
  • Europe Multiplex Assays Market by Value (2015-2019)
  • Europe Multiplex Assays Market Forecast by Value (2020-2024)
  • Latin America Multiplex Assays Market by Value (2015-2019)
  • Latin America Multiplex Assays Market Forecast by Value (2020-2024)
  • Middle East & Africa Multiplex Assays Market by Value (2015-2019)
  • Middle East & Africa Multiplex Assays Market Forecast by Value (2020-2024)
  • Global HIV Infected Population (2015-2019)
  • Global New Cases of Top Cancer Types (2019)
  • Global Medical Technology R&D Spending (2015-2019)
  • Global Geriatric Population - Age 65 and Above (2015-2019)
  • Global Healthcare Expenditure Per Capita (2015-2019)
  • Global Pharmaceutical R&D Spending (2015-2019)
  • Global Growth Rate of Infectious Diseases Forecast (2017-2022)
  • Global Pharmaceutical and Biotech M&A (2015-2019)
  • Thermo Fisher Scientific Revenue and Net Income (2015-2019)
  • Thermo Fisher Scientific Revenue by Segments (2019)
  • Thermo Fisher Scientific Revenue by Regions (2019)
  • Becton, Dickinson and Company Revenue and Net Income (2015-2019)
  • Becton, Dickinson and Company Revenue by Segments (2019)
  • Becton, Dickinson and Company Revenue by Regions (2019)
  • BioMerieux Net Sales and Net Income (2015-2019)
  • BioMerieux Net Sales by Product Application (2019)
  • BioMerieux Net Sales by Regions (2019)
  • Bio-Rad Laboratories Net Sales and Net Income (2015-2019)
  • Bio-Rad Laboratories Net Sales by Segments (2019)
  • Bio-Rad Laboratories Net Sales by Regions (2019)
  • Qiagen Net Sales and Net Loss (Income) (2015-2019)
  • Qiagen Net Sales by Product Classes (2019)
  • Qiagen Net Sales by Regions (2019)
  • Luminex Corporation Total Revenue and Net Loss (Income) (2015-2019)
  • Luminex Corporation Total Revenue by Source (2019)
  • Luminex Corporation Total Revenue by Regions (2019)
Back to Top
전화 문의
F A Q